Literature DB >> 18093256

Similarity of biotechnology-derived medicinal products: specific problems and new regulatory framework.

Jean-Louis Prugnaud.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18093256      PMCID： PMC2291378          DOI： 10.1111/j.1365-2125.2007.03062.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  2 in total

1.  Minimising harm: human variation and adverse drug reactions (ADRs).

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2008-04       Impact factor: 4.335

2.  Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical Trials.

Authors:  Aaron R Hansen; Natalie Cook; M Stacey Ricci; Albiruni Razak; Christophe Le Tourneau; Kathleen McKeever; Lorin Roskos; Rakesh Dixit; Lillian L Siu; Mary Jane Hinrichs
Journal:  Oncologist       Date:  2015-05-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.